Sustainable KLH Technologies for Growing Markets

PRESS RELEASES

Stellar Biotechnologies Announces Publication of “Expert Review” Article on Clostridium difficile Vaccines
Apr 30, 2013
Stellar Biotechnologies, Inc. ("Stellar" or “the Company”) (OTCQB: SBOTF)...  Read More
Stellar Biotechnologies Submits Biological Master File to U.S. FDA for Subunit KLH
Mar 19, 2013
Stellar Biotechnologies, Inc. ("Stellar" or “the Company”) (OTCQB: SBOTF)...  Read More
Subscribe to RSS

Sedar Filing  Edgar Filing

Our platform is Stellar KLH™. Our commitment is to excellence in targeted immune therapies and immunodiagnostics.  

Stellar Biotechnologies is the world leader in sustainable manufacture of Keyhole Limpet Hemocyanin (KLH). We serve the growing demand for this essential molecule and we are focused on applying our expertise to targeted therapeutics and immunodiagnostics. Read more

KLH is an important immune-stimulating protein, highly valued in wide-ranging therapeutic and diagnostic markets. Stellar Biotechnologies revolutionized the KLH industry, turning this vital, natural protein into a renewable, quality resource. Read about Stellar KLH™